IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $546,225 | +11.6% | 12,042 | +1.1% | 0.00% | 0.0% |
| Q2 2023 | $489,350 | -12.1% | 11,913 | -23.5% | 0.00% | 0.0% |
| Q1 2023 | $556,507 | +151.8% | 15,571 | +136.0% | 0.00% | 0.0% |
| Q3 2021 | $221,000 | -36.9% | 6,599 | -15.1% | 0.00% | 0.0% |
| Q1 2021 | $350,000 | -27.5% | 7,772 | -9.0% | 0.00% | -50.0% |
| Q4 2020 | $483,000 | +23.5% | 8,544 | +3.8% | 0.00% | 0.0% |
| Q3 2020 | $391,000 | +30.8% | 8,233 | +62.2% | 0.00% | 0.0% |
| Q2 2020 | $299,000 | +39.7% | 5,075 | +12.3% | 0.00% | 0.0% |
| Q1 2020 | $214,000 | -27.0% | 4,521 | -6.8% | 0.00% | 0.0% |
| Q4 2019 | $293,000 | +6.2% | 4,853 | +5.4% | 0.00% | 0.0% |
| Q3 2019 | $276,000 | -2.1% | 4,605 | +4.9% | 0.00% | 0.0% |
| Q2 2019 | $282,000 | -18.5% | 4,388 | +3.0% | 0.00% | -33.3% |
| Q1 2019 | $346,000 | +32.6% | 4,259 | +1.0% | 0.00% | -66.7% |
| Q4 2015 | $261,000 | – | 4,215 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,136 | $133,749 | 7.12% |
| Bellevue Group AG | 9,743,900 | $368,027,103 | 4.88% |
| M28 Capital Management LP | 126,300 | $4,770,351 | 4.55% |
| Sicart Associates LLC | 246,258 | $9,301,165 | 3.28% |
| Camber Capital Management LP | 1,925,000 | $72,707 | 2.49% |
| Privium Fund Management B.V. | 148,807 | $5,557,941 | 2.11% |
| Deep Track Capital, LP | 1,205,773 | $45,542,046 | 1.91% |
| BVF INC/IL | 1,121,809 | $42,370,726 | 1.79% |
| Orbimed Advisors | 1,993,600 | $75,298,272 | 1.44% |
| Parkman Healthcare Partners LLC | 141,115 | $5,329,914 | 1.42% |